ORAMED PHARMACEUTICALS INC. ORMP Income Statement

Oramed pharmaceuticals inc. (ORMP)

Income statement / TTM

Feb'20	Nov'19	Aug'19	May'19	Feb'19	Nov'18	Aug'18	May'18	Feb'18	Nov'17	Aug'17	May'17	Feb'17	Nov'16	Aug'16	May'16	Feb'16	Nov'15	Aug'15	May'15	Feb'15	Nov'14	Aug'14	May'14	Feb'14	Nov'13	Aug'13	May'13	Feb'13	Nov'12	Aug'12	May'12	Feb'12	Nov'11	Aug'11	May'11	Feb'11	Nov'10
REVENUES
2,711	2,703	2,703	2,639	2,574	2,512	2,449	2,450	2,450	2,457	2,456	2,517	1,737	1,251	641	-38	125	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
COST OF REVENUES
-	-	90	4	0	0	-	0	-	-	187	681	673	677	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
RESEARCH AND DEVELOPMENT EXPENSES
11,403	11,197	13,522	14,056	14,389	13,999	11,979	11,781	9,854	10,255	10,281	17,762	13,785	11,963	7,709	-880	1,745	1,578	4,781	6,295	4,291	3,829	3,277	-3,914	-1,989	-1,914	-2,272	2,513	1,927	1,889	1,681	1,434	1,426	1,056	1,159	0	0	0
IMPAIRMENT OF INVESTMENT
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	0	0	0	0	0	0
GENERAL AND ADMINISTRATIVE EXPENSES
4,197	3,871	3,722	3,929	4,073	3,999	4,083	3,985	3,447	3,307	2,759	4,649	3,589	3,468	2,452	372	1,646	1,454	2,602	4,370	2,837	2,811	2,629	-3,265	-1,952	-1,953	-2,032	1,749	1,541	1,260	1,203	1,107	1,166	1,242	1,275	0	0	0
OPERATING LOSS
-12,889	-12,420	-14,631	-15,436	-15,892	-15,435	-13,527	-13,230	-10,851	-11,105	-10,771	-20,575	-16,310	-14,857	-10,010	474	-3,270	-3,032	-7,383	-10,665	-7,128	-6,640	-5,906	7,179	3,941	3,867	4,304	-4,263	-3,469	-3,149	-2,884	-2,541	-2,592	-2,299	-2,435	0	0	0
FINANCIAL INCOME
880	984	1,061	1,077	1,023	967	903	841	842	828	792	1,006	659	584	474	119	307	217	168	300	170	206	225	-362	-199	-206	-180	221	137	78	13	15	37	37	33	0	0	0
GAIN ON SALE OF INVESTMENT
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	1,033	1,033	1,033	0	0	0
IMPAIRMENT OF AVAILABLE- FOR-SALE SECURITIES
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	140	184	184	240	240	197	197	0	0	0
FINANCIAL EXPENSES
480	497	485	72	87	90	103	108	99	98	101	130	87	100	93	24	47	14	18	32	28	30	11	-650	-640	-610	-313	497	501	478	199	44	41	34	18	0	0	0
LOSS (GAIN) FROM CHANGES IN FAIR VALUE OF INVESTMENT
0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
LOSS BEFORE TAXES ON INCOME
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
LOSS BEFORE TAXES ON INCOME
-	-	-	0	-	-	-	0	0	-	-10,080	-19,581	-15,620	-14,255	-9,629	0	0	0	-	-	-	-	-	-	-	-	-	-	-3,974	-3,734	-3,254	-2,811	-1,803	-1,460	-1,585	0	0	0
TAXES ON INCOME
-	-	-	-	0	-	-	-	-	-	400	1,735	1,735	1,735	1,335	0	0	0	-	-	-	-	-	-	-	-	-	-	90	90	90	-23	-23	-23	-23	0	0	0
NET LOSS FOR THE PERIOD
-12,609	-12,596	-14,355	-7,599	-7,881	-14,498	-12,727	-12,497	-10,108	-10,375	-10,480	-16,536	-12,575	-11,210	-10,964	-4,328	-7,907	-7,726	-7,232	-10,401	-6,990	-6,468	-5,696	7,261	4,177	4,066	4,232	-4,770	-4,064	-3,824	-3,344	-2,787	-1,779	-1,436	-1,561	0	0	0
SUBSEQUENT INCREASE IN THE FAIR VALUE OF AVAILABLE FOR SALE SECURITIES PREVIOUSLY WRITTEN DOWN AS IMPAIRED
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-141	-199	-243	-131	68	102	0	-	0	0	-	-	-	-	-
RECLASSIFICATION ADJUSTMENT FOR GAINS INCLUDED IN NET LOSS
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	80	-151	-96	-72	-90	69	0	0	-	0	-	-	-	-	-	-
RECLASSIFICATION ADJUSTMENT FOR GAINS INCLUDED IN NET LOSS
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-
UNREALIZED INCOME ON AVAILABLE FOR SALE SECURITIES
-	-	-	-	-	-	301	-299	102	684	295	-461	-831	-921	-452	795	942	871	106	-918	-658	-175	228	476	98	-337	-263	117	172	0	-	0	0	-	-	-	-	-
TOTAL OTHER COMPREHENSIVE INCOME
-	-	-	-	-	-	301	-299	102	684	295	-461	-831	-921	-452	795	942	871	106	-1,064	-748	-242	148	487	-4	-508	-304	116	224	0	-	0	0	-	-	-	-	-
SUBSEQUENT INCREASE IN THE FAIR VALUE OF AVAILABLE FOR SALE SECURITIES PREVIOUSLY WRITTEN DOWN AS IMPAIRED
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
UNREALIZED GAIN ON AVAILABLE FOR SALE SECURITIES
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
TOTAL OTHER COMPREHENSIVE INCOME
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
TOTAL COMPREHENSIVE LOSS FOR THE PERIOD
-	-	-	-14,497	-	-	-12,426	-12,796	-10,006	-9,691	-10,185	-21,777	-18,186	-16,911	-11,416	1,247	-2,185	-2,075	-7,126	-11,465	-7,738	-6,710	-5,548	7,749	4,173	3,557	3,928	-4,622	-3,820	-3,592	-3,344	0	0	0	-	-	-	-
LOSS PER SHARE OF COMMON STOCK:
BASIC AND DILUTED LOSS PER SHARE OF COMMON STOCK
0.21	0.15	0.13	0.23	0.21	0.25	0.18	0.30	0.20	0.18	0.20	0.15	0.24	0.20	0.37	0.15	0.14	0.21	0.18	0.15	0.15	0.19	0.18	0.18	0.12	0.14	0.45	0.17	-0.17	0.14	0.30	0.09	0.17	0.01	-0.03	-0.01	0.01	0.01
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING BASIC AND DILUTED LOSS PER SHARE OF COMMON STOCK
17,818	17,472	17,458	17,456	17,454	17,448	16,325	14,518	14,445	14,239	13,450	13,300	13,279	13,205	13,153	13,118	12,652	11,572	11,485	10,827	10,826	10,142	10,019	9,888	9,127	7,941	7,572	7,223	7,212	6,828	-	5,860	5,848	-	-	-	-	-
WEIGHTED AVERAGE NUMBER OF BASIC AND DILUTED SHARES USED IN COMPUTATION OF LOSS PER SHARE:
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	70,104	-	-	-	-
WEIGHTED AVERAGE NUMBER OF SHARES USED IN COMPUTATION OF LOSS (INCOME) PER SHARE: Basic
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	69,049	-	-
WEIGHTED AVERAGE NUMBER OF SHARES USED IN COMPUTATION OF LOSS (INCOME) PER SHARE: Diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	72,410	-	-
WEIGHTED AVERAGE NUMBER OF COMMON STOCK USED IN COMPUTING BASIC AND DILUTED LOSS PER COMMON STOCK
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	62,804	57,932